TickerFacts.

Compare

AbCellera Biologics Inc. vs Bicycle Therapeutics PLC vs Assembly Biosciences, Inc. vs ADC Therapeutics SA

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAbCellera Biologics Inc.
ABCL		Bicycle Therapeutics PLC
BCYC		Assembly Biosciences, Inc.
ASMB		ADC Therapeutics SA
ADCT
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$75.13M$72.59M$72.30M$81.36M
Revenue growth (YoY)+160.6%+105.8%+153.5%+14.9%
Gross marginn/an/an/a92.9% (computed)
Operating margin-289.0%-340.4%-16.8%-149.3%
Net margin-194.9%-301.7%-8.5%-175.3%
Net income-$146.41M-$218.96M-$6.12M-$142.62M
EPS (Diluted)-$0.49-$3.16-$0.55-$1.12
Operating cash flow-$131.29M-$249.68M-$41.09M-$141.17M
Free cash flow-$174.07M-$252.03M-$41.16M-$141.44M
Cash & equivalents$128.51M$628.11M$58.45M$261.34M
Total assets$1.36B$717.60M$257.59M$323.15M
Total liabilities$390.05M$107.62M$50.84M$508.98M
Shareholders' equity$966.90M$609.98M$206.75M-$185.83M
Return on year-end equity-15.1%-35.9%-3.0%n/a
Shares outstanding300.60M69.37M15.86M125.75M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAbCellera Biologics Inc.Bicycle Therapeutics PLCAssembly Biosciences, Inc.ADC Therapeutics SA
Latest$75.13M
Ended 2025-12-31		$72.59M
Ended 2025-12-31		$72.30M
Ended 2025-12-31		$81.36M
Ended 2025-12-31
1 year earlier$28.83M
Ended 2024-12-31		$35.27M
Ended 2024-12-31		$28.52M
Ended 2024-12-31		$70.84M
Ended 2024-12-31
2 years earlier$38.02M
Ended 2023-12-31		$26.98M
Ended 2023-12-31		$7.16M
Ended 2023-12-31		$69.56M
Ended 2023-12-31
3 years earlier$485.42M
Ended 2022-12-31		$14.46M
Ended 2022-12-31		$0
Ended 2022-12-31		$209.91M
Ended 2022-12-31
4 years earlier$375.20M
Ended 2021-12-31		$11.70M
Ended 2021-12-31		$6.25M
Ended 2021-12-31		n/a